UCL research indicates use of diabetes drug in Parkinson ’s disease

University College London (UCL) has carried out a study that indicated the potential of a common diabetes drug called exenatide as a disease-modifying therapy for treating Parkinson ’s disease.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news